NCT06075485View on ClinicalTrials.gov

Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance

RecruitingOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Drug Resistant EpilepsyKetogenic Dieting
Interventions
OTHER

Ketocal

ketogene diet

Trial Locations (1)

59037

RECRUITING

CHRU Lille, Lille

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

Nutricia Nutrition Clinique

INDUSTRY

NCT06075485 - Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance | Biotech Hunter | Biotech Hunter